Indicated for: prevention of influenza
Route of administration: injectable
Substance: split-virion influenza vaccine (vaccine)
ATC: J07BB02 (Antiinfectives for systemic use | Viral vaccines | Influenza vaccines)
The split virion influenza vaccine is used to prevent seasonal flu, a viral illness caused by influenza viruses of types A and B. The vaccine contains fragments of influenza virus obtained by splitting virions, which reduces the risk of adverse reactions and makes it better tolerated, especially by children and the elderly.
The vaccine is administered intramuscularly or subcutaneously, usually annually, and is recommended for all individuals over 6 months of age, especially those in high-risk groups such as the elderly, pregnant women, individuals with chronic illnesses, and healthcare workers.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.
The split virion influenza vaccine is an effective and safe option for preventing seasonal flu, helping to reduce the incidence and severity of the disease and protect public health.